Saturday, July 23, 2016 12:40:06 PM
Read the June 8th Update again:
http://www.bielcorp.com/bioelectronics-company-update-june-8-2016/
1. If a second FDA meeting was requested by BIEL at that time, why didn't BIEL tell us? The tone of the June 8th update certainly implied that the meetings were "one and done."
2. If a second FDA meeting was NOT requested by BIEL at that time, why was the second meeting necessary? What did the FDA tell BIEL that caused BIEL to request another meeting with the FDA?
3. WHY won't BIEL tell us the FDA's pathway decision?
It's not illegal to omit information from these company updates. It certainly is unethical, IMO.
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM